Thompson Siegel & Walmsley’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,606,255	Closed	-$28.3M	–	879
2017 Q3	$28.3M	Sell	1,606,255 -816,227	-34%	-$18.4M	0.34%	86
2017 Q2	$80.5M	Buy	2,422,482 +49,885	+2%	+$1.54M	0.95%	35
2017 Q1	$76.1M	Sell	2,372,597 -1,888,255	-44%	-$64.4M	0.89%	29
2016 Q4	$154M	Buy	4,260,852 +984,040	+30%	+$39.3M	2.03%	1
2016 Q3	$151M	Buy	3,276,812 +762,044	+30%	+$39.8M	2.34%	1
2016 Q2	$126M	Buy	2,514,768 +282,843	+13%	+$15.1M	1.99%	1
2016 Q1	$119M	Buy	2,231,925 +361,070	+19%	+$21.2M	1.94%	1
2015 Q4	$123M	Buy	1,870,855 +362,150	+24%	+$22.4M	2.21%	1
2015 Q3	$85.2M	Buy	1,508,705 +350,040	+30%	+$22.7M	1.59%	2
2015 Q2	$68.5M	Buy	1,158,665 +72,020	+7%	+$4.44M	1.21%	5
2015 Q1	$67.7M	Buy	1,086,645 +1,086,450	+557,154%	+$63.2M	1.17%	5
2014 Q4	$11K	Hold	195	–	–	﹤0.01%	621
2014 Q3	$10K	Hold	195	–	–	﹤0.01%	621
2014 Q2	$10K	Hold	195	–	–	﹤0.01%	604
2014 Q1	$10K	Sell	195 -700	-78%	-$32.4K	﹤0.01%	589
2013 Q4	$36K	Sell	895 -4,275	-83%	-$168K	﹤0.01%	482
2013 Q3	$195K	Sell	5,170 -679,918	-99%	-$26.5M	﹤0.01%	389
2013 Q2	$26.9M	Buy	+685,088	New	+$26.7M	0.58%	45